Severe Gastrointestinal Disease: Conditions like gastroparesis (slow stomach emptying) can be exacerbated by Tirzepatide, which naturally slows digestion
Other laboratory abnormalities include macrocytic anaemia due to folate (or, rarely, vitamin B 12 ) deficiency, coagulopathy resulting from vitamin K deficiency, or vitamin D deficiency leading to hypocalcaemia and an elevated alkaline phosphatase level.[8] Other increasingly recognised extra intestinal manifestations include bone fractures,[9] infertility,[10] psychiatric syndromes,[11] and various neurologic conditions, including peripheral neuropathy, ataxia, and seizures.[12] Autoimmune diseases occur more commonly in patients with coeliac sprue, especially type 1 diabetes mellitus[13] and autoimmune thyroiditis.[14] The prevalence of coeliac sprue in patients with type 1 diabetes is approximately 3 to 8 percent.[15] Comment The incidence of CD is increasing across all age ranges and yet remains grossly underdiagnosed
All drugs in this class carry similar risks of: Severe gastroparesis Intestinal blockage Persistent vomiting Other gastrointestinal complications If youre experiencing side effects: Report them to your doctor immediately Do not stop abruptly without medical guidance Consider whether continuing is worth the risks Discuss all alternatives including non-GLP-1 options for diabetes or weight management Get objective testing (gastric emptying scan) if you have severe GI symptoms Better alternatives to discuss with your doctor: Traditional diabetes medications (metformin, insulin, SGLT2 inhibitors) Non-GLP-1 weight loss medications Lifestyle interventions with medical supervision Surgical options if appropriate Q: Can I file a lawsuit if I took a GLP-1 drug for diabetes instead of weight loss
Anti-Inflammatory & Immune Modulation KPV and BPC-157 reduce pro-inflammatory cytokines (TNF-, IL-6) and modulate NF-B pathways, providing insight into chronic inflammation models [2]
